| Dec 9, 2025 |
Dec 9, 2025 |
Heyman Tomas J.
|
Director |
Neutral |
47.5
|
-9,398
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Xu Yuan
|
Director |
Neutral |
47.5
|
-9,398
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Cheng Andrew
|
CEO |
Neutral |
27.5
|
-436,837
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Harrison Seth Loring
|
Director |
Neutral |
27.5
|
-293,762
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Graham G. Walmsley
|
Director |
Neutral |
27.5
|
-1,302,398
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Judy Chou
|
Director |
Neutral |
47.5
|
-9,398
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Neutral |
27.5
|
-282,149
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Iwicki Mark T
|
Director |
Neutral |
47.5
|
-9,398
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Gangloff Scott A.
|
Chief Technology Officer |
Neutral |
27.5
|
-26,351
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
White William Richard
|
CFO |
Neutral |
27.5
|
-57,752
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Yale Catriona
|
Chief Development Officer |
Neutral |
27.5
|
-74,800
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Lamy Patrick
|
Officer |
Neutral |
27.5
|
-29,891
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Henderson Jane
|
Director |
Neutral |
47.5
|
-9,398
|
-100.00%
|
✗
|
- |
| Dec 9, 2025 |
Dec 9, 2025 |
Young Jonathan
|
COO |
Neutral |
27.5
|
-260,189
|
-100.00%
|
✗
|
- |
| Nov 25, 2025 |
Nov 28, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 24, 2025 |
Nov 26, 2025 |
Young Jonathan
|
COO |
Neutral |
27.5
|
-9,259
|
-3.44%
|
✗
|
- |
| Nov 20, 2025 |
Nov 21, 2025 |
Cheng Andrew
|
CEO |
Neutral |
27.5
|
-74,538
|
-14.58%
|
✗
|
- |
| Nov 17, 2025 |
Nov 19, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Neutral |
27.5
|
-37,100
|
-22.27%
|
✗
|
- |
| Nov 12, 2025 |
Nov 13, 2025 |
Cheng Andrew
|
CEO |
Neutral |
27.5
|
-14,739
|
-2.80%
|
✗
|
- |
| Nov 4, 2025 |
Nov 6, 2025 |
Yale Catriona
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 10, 2025 |
Oct 14, 2025 |
Cheng Andrew
|
CEO |
Sell |
27.5
|
-30,000
|
-5.39%
|
✓
|
$1.6M |
| Oct 8, 2025 |
Oct 10, 2025 |
Graham G. Walmsley
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 7, 2025 |
Oct 9, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
30.0
|
-12,500
|
-6.98%
|
✓
|
$576K |
| Oct 8, 2025 |
Oct 9, 2025 |
Cheng Andrew
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
Young Jonathan
|
COO |
Sell |
35.0
|
-12,500
|
-4.64%
|
✓
|
$597K |
| Sep 11, 2025 |
Sep 12, 2025 |
Young Jonathan
|
COO |
Sell |
51.3
|
-586
|
-0.23%
|
✗
|
$25.2K |
| Sep 11, 2025 |
Sep 12, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
48.8
|
-659
|
-0.72%
|
✗
|
$28.4K |
| Sep 11, 2025 |
Sep 12, 2025 |
White William Richard
|
CFO |
Sell |
46.3
|
-659
|
-1.13%
|
✗
|
$28.4K |
| Sep 11, 2025 |
Sep 12, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
51.3
|
-553
|
-0.33%
|
✗
|
$23.8K |
| Sep 10, 2025 |
Sep 12, 2025 |
Cheng Andrew
|
CEO |
Sell |
27.5
|
-31,796
|
-6.29%
|
✓
|
$1.4M |
| Sep 8, 2025 |
Sep 10, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
30.0
|
-12,500
|
-6.96%
|
✓
|
$552.1K |
| Sep 2, 2025 |
Sep 4, 2025 |
Young Jonathan
|
COO |
Sell |
35.0
|
-12,500
|
-4.63%
|
✓
|
$576K |
| Aug 15, 2025 |
Aug 19, 2025 |
Gangloff Scott A.
|
Chief Technology Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 12, 2025 |
Aug 13, 2025 |
Young Jonathan
|
COO |
Sell |
35.0
|
-12,500
|
-4.63%
|
✓
|
$597.3K |
| Aug 11, 2025 |
Aug 13, 2025 |
Cheng Andrew
|
CEO |
Sell |
27.5
|
-30,000
|
-5.76%
|
✓
|
$1.5M |
| Aug 12, 2025 |
Aug 12, 2025 |
Henderson Jane
|
Director |
Sell |
22.5
|
-3,000
|
-24.20%
|
✗
|
$142.4K |
| Aug 5, 2025 |
Aug 7, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
30.0
|
-12,500
|
-6.96%
|
✓
|
$616.3K |
| Jul 16, 2025 |
Jul 18, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
26.3
|
-10,000
|
-9.85%
|
✓
|
$529.5K |
| Jul 10, 2025 |
Jul 11, 2025 |
Cheng Andrew
|
CEO |
Sell |
27.5
|
-30,000
|
-5.45%
|
✓
|
$1.5M |
| Jul 7, 2025 |
Jul 9, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
30.0
|
-12,500
|
-6.96%
|
✓
|
$638.7K |
| Jul 1, 2025 |
Jul 3, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
32.5
|
-2,000
|
-6.27%
|
✓
|
$105.8K |
| Jun 30, 2025 |
Jul 2, 2025 |
Yale Catriona
|
Chief Development Officer |
Neutral |
67.5
|
+890
|
0.98%
|
✗
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
Young Jonathan
|
COO |
Neutral |
60.0
|
+890
|
0.35%
|
✗
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Neutral |
67.5
|
+193
|
0.61%
|
✗
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
White William Richard
|
CFO |
Neutral |
77.5
|
+890
|
1.55%
|
✗
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Neutral |
67.5
|
+890
|
0.54%
|
✗
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
Gangloff Scott A.
|
Chief Technology Officer |
Neutral |
77.5
|
+299
|
1.27%
|
✗
|
- |
| Jun 30, 2025 |
Jul 2, 2025 |
Cheng Andrew
|
CEO |
Neutral |
55.0
|
+890
|
0.16%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Cheng Andrew
|
CEO |
Sell |
40.0
|
-6,620
|
-1.19%
|
✗
|
$363K |
| Jun 18, 2025 |
Jun 20, 2025 |
Gangloff Scott A.
|
Chief Technology Officer |
Sell |
46.3
|
-848
|
-3.49%
|
✗
|
$46.5K |
| Jun 20, 2025 |
Jun 20, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
46.3
|
-875
|
-2.69%
|
✗
|
$47.8K |
| Jun 18, 2025 |
Jun 20, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
45.0
|
-1,129
|
-0.67%
|
✗
|
$61.9K |
| Jun 18, 2025 |
Jun 20, 2025 |
White William Richard
|
CFO |
Sell |
42.5
|
-1,634
|
-2.76%
|
✗
|
$89.6K |
| Jun 18, 2025 |
Jun 20, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
42.5
|
-1,633
|
-1.77%
|
✗
|
$89.6K |
| Jun 18, 2025 |
Jun 20, 2025 |
Young Jonathan
|
COO |
Sell |
45.0
|
-1,453
|
-0.56%
|
✗
|
$79.7K |
| Jun 16, 2025 |
Jun 20, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
26.3
|
-10,000
|
-9.78%
|
✓
|
$542.3K |
| Jun 16, 2025 |
Jun 20, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
32.5
|
-2,000
|
-5.78%
|
✓
|
$108.3K |
| Jun 10, 2025 |
Jun 12, 2025 |
Cheng Andrew
|
CEO |
Sell |
27.5
|
-37,837
|
-6.37%
|
✓
|
$2M |
| Jun 10, 2025 |
Jun 12, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
42.5
|
-2,358
|
-1.39%
|
✗
|
$127.3K |
| Jun 10, 2025 |
Jun 12, 2025 |
White William Richard
|
CFO |
Sell |
42.5
|
-2,804
|
-4.53%
|
✗
|
$151.4K |
| Jun 10, 2025 |
Jun 12, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
42.5
|
-2,803
|
-2.95%
|
✗
|
$151.4K |
| Jun 10, 2025 |
Jun 12, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
46.3
|
-919
|
-2.74%
|
✗
|
$49.6K |
| Jun 10, 2025 |
Jun 12, 2025 |
Young Jonathan
|
COO |
Sell |
45.0
|
-2,493
|
-0.96%
|
✗
|
$134.6K |
| Jun 5, 2025 |
Jun 9, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
27.5
|
-37,500
|
-6.82%
|
✓
|
$2M |
| Jun 3, 2025 |
Jun 5, 2025 |
Henderson Jane
|
Director |
Neutral |
90.0
|
+9,398
|
100.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 5, 2025 |
Harrison Seth Loring
|
Director |
Neutral |
82.5
|
+9,398
|
3.30%
|
✗
|
- |
| Jun 3, 2025 |
Jun 5, 2025 |
Iwicki Mark T
|
Director |
Neutral |
90.0
|
+9,398
|
100.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 5, 2025 |
Xu Yuan
|
Director |
Neutral |
90.0
|
+9,398
|
100.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 5, 2025 |
Heyman Tomas J.
|
Director |
Neutral |
90.0
|
+9,398
|
100.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 5, 2025 |
Judy Chou
|
Director |
Neutral |
90.0
|
+9,398
|
100.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 5, 2025 |
Graham G. Walmsley
|
Director |
Neutral |
67.5
|
+9,398
|
0.78%
|
✗
|
- |
| Jun 2, 2025 |
Jun 4, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
25.0
|
-4,000
|
-10.67%
|
✓
|
$201.3K |
| May 22, 2025 |
May 23, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
25.0
|
-4,000
|
-10.67%
|
✓
|
$200K |
| May 15, 2025 |
May 19, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
26.3
|
-10,000
|
-9.52%
|
✓
|
$393K |
| May 12, 2025 |
May 13, 2025 |
Cheng Andrew
|
CEO |
Sell |
32.5
|
-30,000
|
-4.81%
|
✓
|
$1.2M |
| May 7, 2025 |
May 9, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
17.5
|
-8,000
|
-19.28%
|
✓
|
$340K |
| May 6, 2025 |
May 8, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
30.0
|
-12,500
|
-6.86%
|
✓
|
$542.9K |
| Apr 24, 2025 |
Apr 28, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
35.0
|
-6,250
|
-3.55%
|
✓
|
$256.4K |
| Apr 15, 2025 |
Apr 16, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
26.3
|
-9,073
|
-8.72%
|
✓
|
$344K |
| Apr 10, 2025 |
Apr 11, 2025 |
Cheng Andrew
|
CEO |
Sell |
32.5
|
-30,000
|
-4.58%
|
✓
|
$1.1M |
| Apr 7, 2025 |
Apr 10, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
37.5
|
-6,250
|
-3.55%
|
✓
|
$224.3K |
| Mar 25, 2025 |
Mar 27, 2025 |
Graham G. Walmsley
|
Director |
Buy |
100.0
|
+200,000
|
19.96%
|
✗
|
$8.8M |
| Mar 17, 2025 |
Mar 18, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
26.3
|
-10,000
|
-9.52%
|
✓
|
$447.6K |
| Mar 12, 2025 |
Mar 14, 2025 |
Cheng Andrew
|
CEO |
Sell |
47.5
|
-1,738
|
-0.26%
|
✗
|
$78K |
| Mar 12, 2025 |
Mar 14, 2025 |
Young Jonathan
|
COO |
Sell |
51.3
|
-607
|
-0.23%
|
✗
|
$27.2K |
| Mar 12, 2025 |
Mar 14, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
48.8
|
-614
|
-0.64%
|
✗
|
$27.6K |
| Mar 12, 2025 |
Mar 14, 2025 |
White William Richard
|
CFO |
Sell |
46.3
|
-676
|
-1.08%
|
✗
|
$30.3K |
| Mar 12, 2025 |
Mar 14, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
51.3
|
-516
|
-0.30%
|
✗
|
$23.2K |
| Mar 10, 2025 |
Mar 12, 2025 |
Cheng Andrew
|
CEO |
Sell |
32.5
|
-30,000
|
-4.37%
|
✓
|
$1.3M |
| Mar 5, 2025 |
Mar 7, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
30.0
|
-12,500
|
-6.84%
|
✓
|
$556.6K |
| Mar 4, 2025 |
Mar 5, 2025 |
Young Jonathan
|
COO |
Sell |
15.0
|
-50,000
|
-16.07%
|
✓
|
$2.2M |
| Mar 3, 2025 |
Mar 5, 2025 |
Lamy Patrick
|
Senior VP, Commercial Strategy |
Sell |
45.0
|
-1,000
|
-2.90%
|
✓
|
$48.1K |
| Feb 18, 2025 |
Feb 21, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
26.3
|
-10,000
|
-9.47%
|
✓
|
$498.7K |
| Feb 10, 2025 |
Feb 11, 2025 |
Cheng Andrew
|
CEO |
Sell |
32.5
|
-30,000
|
-4.19%
|
✓
|
$1.6M |
| Jan 30, 2025 |
Feb 7, 2025 |
Graham G. Walmsley
|
Director |
Buy |
100.0
|
+200,000
|
24.93%
|
✗
|
$9.6M |
| Feb 5, 2025 |
Feb 7, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
23.8
|
-18,750
|
-9.92%
|
✓
|
$1.1M |
| Feb 3, 2025 |
Feb 5, 2025 |
Young Jonathan
|
COO |
Sell |
35.0
|
-10,000
|
-3.11%
|
✓
|
$538.1K |
| Jan 27, 2025 |
Jan 31, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
5.0
|
-53,590
|
-35.91%
|
✓
|
$3M |
| Jan 27, 2025 |
Jan 31, 2025 |
Yale Catriona
|
Chief Development Officer |
Sell |
5.0
|
-49,074
|
-33.91%
|
✓
|
$2.7M |
| Jan 27, 2025 |
Jan 29, 2025 |
Rolph Timothy
|
Chief Scientific Officer |
Sell |
15.0
|
-31,250
|
-15.51%
|
✓
|
$1.7M |